Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,036 | 54 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $269.10 | 16 | $0 (2024) |
| Amgen Inc. | $182.63 | 5 | $0 (2024) |
| Lilly USA, LLC | $159.57 | 9 | $0 (2024) |
| ABBVIE INC. | $147.94 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $65.54 | 4 | $0 (2024) |
| Axsome Therapeutics, Inc. | $51.86 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.01 | 1 | $0 (2024) |
| Phadia US Inc. | $27.11 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $19.14 | 1 | $0 (2024) |
| UCB, Inc. | $18.26 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $496.49 | 29 | Lilly USA, LLC ($81.72) |
| 2023 | $539.49 | 25 | Novo Nordisk Inc ($197.71) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Endocrinology | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $30.01 | General |
| 08/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Inflammation | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diabetes | ||||||
| 07/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Obesity | ||||||
| 05/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Respiratory | ||||||
| 04/25/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Immunology | ||||||
| 04/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: PAIN | ||||||
| 04/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Dermatology | ||||||
| 04/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.76 | General |
| 04/02/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Diabetes | ||||||
| 03/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.76 | General |
| 03/14/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $13.09 | General |
| Category: Allergy/Immunology | ||||||
| 03/05/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Diabetes | ||||||
| 02/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Respiratory | ||||||
| 02/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 350 | 394 | $91,026 | $24,016 |
| 2022 | 7 | 117 | 138 | $32,538 | $7,049 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 155 | $42,947 | $12,057 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 30 | $5,880 | $1,735 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 30 | 34 | $9,962 | $1,697 | 17.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,711 | $1,498 | 26.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 17 | 17 | $3,672 | $1,289 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 29 | 33 | $6,534 | $1,259 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $4,667 | $1,241 | 26.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,972 | $991.78 | 50.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $5,200 | $983.72 | 18.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 15 | $3,135 | $683.05 | 21.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 17 | 17 | $680.00 | $372.30 | 54.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 20 | 22 | $666.00 | $209.44 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 31 | 39 | $7,722 | $1,703 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 19 | 19 | $5,567 | $1,156 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $5,600 | $1,113 | 19.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 15 | $4,515 | $1,028 | 22.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 20 | $4,180 | $946.33 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 12 | 12 | $2,940 | $653.40 | 22.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 14 | 19 | $2,014 | $449.73 | 22.3% |
About Maghan Walker, NP
Maghan Walker, NP is a Family healthcare provider based in Clayton, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2021. The National Provider Identifier (NPI) number assigned to this provider is 1104417302.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Maghan Walker, NP has received a total of $1,036 in payments from pharmaceutical and medical device companies, with $496.49 received in 2024. These payments were reported across 54 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,036).
As a Medicare-enrolled provider, Walker has provided services to 467 Medicare beneficiaries, totaling 532 services with total Medicare billing of $31,065. Data is available for 2 years (2022–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Clayton, NC
- Active Since 01/30/2021
- Last Updated 02/25/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1104417302
Products in Payments
- Repatha (Biological) $125.00
- MOUNJARO (Drug) $114.29
- Wegovy (Drug) $100.82
- VRAYLAR (Drug) $83.11
- Rybelsus (Drug) $80.94
- Otezla (Drug) $57.63
- Auvelity (Drug) $51.86
- UBRELVY (Drug) $49.47
- AIRSUPRA (Drug) $45.93
- Ozempic (Drug) $45.88
- JARDIANCE (Drug) $27.46
- ImmunoCAP (Device) $27.11
- FARXIGA (Drug) $19.61
- COSENTYX (Drug) $19.14
- Cimzia (Drug) $18.26
- EMGALITY (Drug) $17.82
- ONZETRA XSAIL (Drug) $17.37
- Dexcom G6 Transmitter (Medical Supply) $17.33
- QULIPTA (Drug) $15.36
- NURTEC ODT (Drug) $15.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Clayton
Mrs. Deborah Roberson, F.n.p, F.N.P
Family — Payments: $5,630
Amanda Smith
Family — Payments: $1,927
Mrs. Brittany Mccall, Fnp-C, FNP-C
Family — Payments: $1,710
Brittany Venable, Fnp, FNP
Family — Payments: $1,550
Miss. Guylante Jeune, Np, NP
Family — Payments: $1,191
Mrs. Amanda Rosen
Family — Payments: $823.58